Neuraxis NRXS
NYSE NRXS
$7.32 +0.14 (+2.02%)
As of: Oct 2, 2026 · 10:52 AM EDT

Neuraxis (NRXS) Non-Current Debt (2023)

Updated

Neuraxis (NRXS) posted Non-Current Debt of $38,797 for Q2 2023.

Analysis

Neuraxis (NRXS) Non-Current Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 39.18 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 29.60 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 25.15 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 25.62 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 14.19 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 10.92 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 598.70 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 13.51 Bn
10 Neuraxis 91.64 Mn 66.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 38,797.00
API Access

Neuraxis Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NRXS&period=max&api_key=YOUR_API_KEY